search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Palliative care for patients with irresectable or recurrent cancer of the upper gastrointestinal tract: a randomized study.


- candidate number2098
- NTR NumberNTR687
- ISRCTNISRCTN86515732
- Date ISRCTN created19-jul-2006
- date ISRCTN requested4-jul-2006
- Date Registered NTR19-mei-2006
- Secondary IDsMEC-2005-176 
- Public TitlePalliative care for patients with irresectable or recurrent cancer of the upper gastrointestinal tract: a randomized study.
- Scientific TitleNurse-led follow up at home or conventional medical follow-up at the outpatient clinic of patients with irresectable or recurrent cancer of the upper gastrointestinal tract: a randomized study comparing quality of life, satisfaction and costs.
- ACRONYMPACT study.
- hypothesisDoes nurse-led follow up at home lead to improved quality of life an satifaction and a reduction of costs compared to medical follow up at the outpatient clinic, without compromising the medical condition of patients?
- Healt Condition(s) or Problem(s) studiedHepatobiliary cancer
- Inclusion criteria1. Patients with irresectabel of recurrent esophageal-, pancreatic- and hepatobiliary cancer, for whom no curative treatment options are available; 2. Informed consent.
- Exclusion criteria1. Not able to understand or read the Dutch language; 2. Undergoing treatment with chemotherapy or radiotherapy or a combination.
- mec approval receivedyes
- multicenter trialno
- randomisedyes
- masking/blindingNone
- controlActive
- groupParallel
- Type-
- Studytypeintervention
- planned startdate 1-jun-2006
- planned closingdate1-jan-2009
- Target number of participants150
- InterventionsNurse led follow up at home at 2-weekly and later monthly intervals until month 13 or death versus medical follow up at the outpatient clinic at 1 month and thereafter every 2 months until month 13 or death.
- Primary outcomeQuality of life (questionnaires).
- Secondary outcomePatient satisfaction (questionnaire) costs.
- Timepoints
- Trial web siteN/A
- statusopen: patient inclusion
- CONTACT FOR PUBLIC QUERIESMD. PhD. P.D. Siersema
- CONTACT for SCIENTIFIC QUERIESDrs. M.J. Uitdehaag
- Sponsor/Initiator Erasmus Medical Center, Department of Hepatology and Gastroenterology
- Funding
(Source(s) of Monetary or Material Support)
Erasmus Medical Center
- PublicationsN/A
- Brief summaryFor patients with irresectabel of recurrent esophageal-, pancreatic- or hepatobiliary cancer, no curative treatment options are available. The median survival for this group is only 2-10 months. The treatment aim in the palliative phase is to improve the quality of life of patients and their family, through the prevention and relief of suffering by means of the identification and treatment of pain and other physical, psychosocial and spiritual problems. The high degree of physical and psychological problems in this phase suggest a need for close monitoring and support. Presently, patients in the palliative phase of their disease visit the outpatient clinic for medical follow up. The frequency is usually low with a mean of every 8 weeks. These visits to the hospital are a burden for the majority of patients. We hypothesized that nurse-led follow up at home could be a valuable alternative for these patients. This study will evaluate nurse-led follow up for palliative GI cancer patients by home visits. Outcome will be compared with the usual medical follow up at the outpatient clinic. Outcome measures are: quality of life, patient satisfaction and costs.
- Main changes (audit trail)
- RECORD19-mei-2006 - 20-jul-2006


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl